ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Anova Innovation Limited
Anova Innovation Limited
Actuate Therapeutics Inc.
ImmunityBio, Inc.
Eli Lilly and Company
Engeneic Pty Limited
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Ascentage Pharma Group Inc.
Tyligand Pharmaceuticals (Suzhou) Limited
Trishula Therapeutics, Inc.
Purple Biotech Ltd.
Sumitomo Pharma America, Inc.
Corcept Therapeutics
Jazz Pharmaceuticals